Minimally invasive transcatheter aortic valve replacement (TAVR) has become a growing option for high-risk patients with aortic stenosis. At Piedmont Heart’s 3-D Echo 360 Conference in Atlanta, Dr. Randy Martin of the Marcus Heart Valve Center asks Dr. Vivek Rajagopal, co-director of the transcatheter valve program at Marcus, and Dr. Scott Lim, medical director of the Advanced Cardiac Valve Center at the University of Virginia, about the current state of the technology and future projections; how TAVR is benefitting patients; and how to improve outcomes and control cost.